We are an early-stage, venture-backed start-up that has raised over $50M from top-tier investors in Europe and the United States. We have developed and brought to market the world’s first continuous blood pressure monitor. Our technology is based on 15 years of research by our founders at the prestigious Swiss Center for Electronics and Microtechnology (CSEM). Aktiia's solution has been validated through extensive clinical trials and received a CE Mark as a Class IIa medical device giving us commercial access to 43 countries worldwide.
High blood pressure is the world’s most common disease and...